MedTrace Logo

Brain Imaging: Cocaine Effects & Medication Development - 5

NCT00000270 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-08-02

No results posted yet for this study

Summary

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Cocaine

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Herbert Kleber, M.D. · New York State Psychiatric Institute

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-12-30
Primary Completion
1995-12-30
Completion
1995-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000270 on ClinicalTrials.gov